Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists May Provide a Superior Treatment for Pain and Migraine
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTTransient Receptor Potential Ankyrin 1 (TRPA1) Antagonists May Provide a Superior Treatment for Pain and MigraineAhmed F. Abdel-Magid*Ahmed F. Abdel-MagidTherachem Research Medilab LLC, 100 Jade Park, Chelsea, Alabama 35043, United States*Email: [email protected]More by Ahmed F. Abdel-Magidhttps://orcid.org/0000-0001-7438-1414Cite this: ACS Med. Chem. Lett. 2021, 12, 8, 1193–1195Publication...
Paper Details
Title
Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists May Provide a Superior Treatment for Pain and Migraine
Published Date
Jun 29, 2021
Volume
12
Issue
8
Pages
1193 - 1195
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History